Special issue: “MET as actionable target in cancer therapy”

類似資料

• MET/HGF pathway activation as a paradigm of resistance to targeted therapies
  著者:: Ko, Brian, 等
  出版事項: (2017)
• MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy
  著者:: Pilotto, Sara, 等
  出版事項: (2017)
• Special issue on personalized therapy in lung cancer
  著者:: Zhang, Na, 等
  出版事項: (2014)
• MET targeted therapy for lung cancer: clinical development and future directions
  著者:: Feng, Yan, 等
  出版事項: (2012)
• MET: roles in epithelial-mesenchymal transition and cancer stemness
  著者:: Jeon, Hye-Min, 等
  出版事項: (2017)